FDA Finalizes the Definitions of 'Suspect and Illegitimate' Pharma Products
Industry is still scrambling to handle clerical errors of DSCSA transactions.
HDA’s 2023 Distribution Management Conference Dives into DSCSA Specifics and More
Event—taking place in Indianapolis—places supply chain education at the forefront.
NABP Hopes to Fill a Key Gap in DSCSA Compliance: Local Pharmacies
The Pulse online service will provide free resources to enable pharmacy to meet drug traceability rules.
Advancing ‘Smart Pharma’ Capabilities in 2023 and Beyond
Q&A explores new opportunities to strengthen supply chain resilience—and build on the lessons learned.
Arranta Bio Doubles RNA Process Development Capacity at Massachusetts Plant
Project addresses customer demand in GMP-powered advanced therapeutics.
InVita Healthcare Technologies Launches Counterfeit Drug Testing Software
In an effort to strengthen supply chain, unnamed pharma company to use chain of custody application to combat an illegal global market worth up to $200 billion annually.
Evonik Opens Pharmaceutical Lipids Facility in Germany
New site is expected to complement CDMO’s commercial production experience.
Framework Solutions Gains Additional Regulatory Operations Experience, Purchases Onix Life Sciences
Acquisition expands company’s eCTD submission capabilities.
Congress Probes PBM Link to Higher Drug Prices
Latest investigation signals more scrutiny of pharmacy benefit managers and their role in treatment cost and coverage.
Dr. Reddy’s Acquires Mayne Pharma Portfolio
The deal—potentially totaling upwards of $100 million—strengthens the company’s selection of US generic prescription products.
IATA Air Freight Numbers Indicate a Soft Start to the Year
Stats point to a 14.9% decline compared to January of last year.
Introducing GDP-UCI: A New Medicines and Vaccines Reform Program
Initiative intends to facilitate regulatory compliance within the pharma distribution space.
Fresenius Kabi Introduces Unit-of-Use 2D Barcodes
With the help of traceability, new feature prioritizes efficiency and safety, from production to patient.
SGD Pharma, Corning Commit to Packaging Expansion Deal in India
Hoping to accelerate the drug delivery process, production is expected to begin as early as 2025.
Everest Medicines Begins Operations at mRNA Facility
Following numerous successful trial runs, vaccine production is expected to reach 700 million.
RoslinCT, Lykan Biosciences Add Six cGMP Suites to Massachusetts Facility
Expansion expected to increase global capacity by 75%.
Peli BioThermal Adds New Capabilities to Dry Ice Portfolio
Enhancements to help keep products frozen for over 144 hours, company says.
Porton Advanced, Yinjia Biosciences Partner Up on CGTs
Joint venture revolves around around the use of raw materials for the development—and ultimately commercialization—of therapies.
PackGene Biotech Commences Construction on cGMP Complex
New 25,000 square-foot facility will help grow customers’ gene therapy programs.
Beghou Consulting Unveils New India Office
Site expected to support growth of advanced analytics and data science team.
Report: Cold Chain Packaging Market Predicted to Reach Upwards of $103.7B by 2033
Pharma sector, FMI report says, is quickly growing, due to globalization and development of low-cost medications.
Construction on Agilent’s $725M Colorado Expansion Project Now Underway
Facility addition expected to increase production capacity of TNAs.
Carrier Financially Commits to Cold Chain Offshoot, Ember LifeSciences
Investment helps encourage sustainability in the space, especially as it pertains to pharma, company says.
Dalton Grows Sterile Manufacturing Capacity
cGMP line will fill vials, syringes, and cartridges, while supporting small-scale commercial production.
Cloud Technology Is Favored Method for Tackling Labeling and Supply Chain Challenges, Survey Says
Conclusion driven by various factors, including product shortages and cost pressures.
LATAM Cargo Sees 16% Increase in Flower Shipments Compared to Last Valentine’s Day
Flights from Colombia and Ecuador more than doubled during the season, resulting in exports of nearly 18,000 tons.
GC Biopharma Plant Obtains WHO Pre-Qualification
South Korea facility expected to provide fill-finish capabilities.
Genentech Breaks Ground on Manufacturing Facility
New California plant expected to streamline medicine production.
Dipharma Completes Second Stage of US Facility Expansion
Investment expected to establish additional cGMPs, expand CDMO services.
HDA Seeks to Limit FDA Enforcement Discretion of DSCSA Come November, Raising the Burden on Some Manufacturers
Meanwhile, PDG issues more DSCSA guidance on data interoperability.
